Publication | Closed Access

Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction

CardiomyopathyHeart FailureCardiovascular DiseaseLeft Ventricular DysfunctionMedicineDiabetesMyocardial InfarctionCardiac Metaiodobenzylguanidine UptakePharmacotherapyInitial LossPublic HealthPharmacologyCardiologyDiastolic FunctionAnesthesiologyCardiovascular Imaging